Raised plasma adrenomedullin in patients with systemic sclerosis complicated by pulmonary hypertension [4]

Annals of the Rheumatic Diseases

Volumn 59, Issue 6, 2000, Pages 493-494

  Nanke, Yuki ^a   Kotake, Shigeru ^a   Akama, Hideto ^a   Shimamoto, Ken ^a   Hara, Masako ^a   Kamatani, Naoyuki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; CHEMOATTRACTANT; CYCLIC AMP; ENDOTHELIN 1;

ADULT; AGED; AMINO ACID SEQUENCE; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOASSAY; LETTER; LUNG ARTERY PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC SCLEROSIS; VASCULAR SMOOTH MUSCLE;

ADRENOMEDULLIN; ADULT; AGED; CASE-CONTROL STUDIES; ENDOTHELIN-1; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PEPTIDES; SCLERODERMA, SYSTEMIC;

EID: 0034080322     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. 1 Kitamura K, Kanagawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993;192:553-60.
2. 2 Hayashi M, Shimosawa T, Isaka M, Yamada S, Fujita R, Fujita T. Plasma adrenomedullin in diabetes. Lancet 1997;350:1449-50.
3. 3 Kitamura K, Kanagawa K, Matsuo H, Eto T. Structure and function of adrenomedullin and PAMP. In: Martinez A, Cuttitta F, eds. Adrenomedullin, Amsterdam: IOS press, 1998; 27-39.
4. 4 Kamoi H, Kanazawa H, Hirata K, Kurihara N, Yano Y, Otani S. Adrenomedullin inhibits the secretion of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, from rat alveolar macrophages. Biochem Biophys Res Commun 1995; 211:1031-5.
5. 5 Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993; 328:1732-9.
6. 6 Letizia C, Danese C, D'Erasmo E. Increased plasma adrenomedullin concentrations in patients with Raynaud's phenomenon. J Rheumatol 1999;26:759-60.
7. 7 Yudoh K, Matsuno H, Kimura T. Plasma adrenomedullin in rheumatoid arthritis compared with rheumatic diseases. Arthritis Rheum 1999;42:1297-8.
8. 8 Medsger TA Jr, Steen VD. Classification, prognosis. In: Clements PJ, Furst DE, eds. Systemic sclerosis. Baltimore: Williams and Wilkins, 1996:51-64.
9. 9 Yoshihara F, Nishikimi T, Horio T, Yutani C, Takishita S, Matsuo H, et al. Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens right ventricular hypertrophy in rats administered monocrotaline. Eur J Pharmacol 1998;355:33-9.